首页 >
法规速递
-
ICH M12 on drug interaction studies - Scientific guideline-2022/12/12
2022-12-13查看详情 > -
Regulatory and procedural guideline: Guidance for applicants/MAHs involved in GMP, GCP and GVP inspections coordinated by EMA-2022/12/12
2022-12-13查看详情 > -
Regulatory and procedural guideline: ICH guideline Q3C (R8) on impurities: guideline for residual solvents - Step 5-2022/11/28
2022-11-30查看详情 > -
Scientific guideline: Draft reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations-2022/11/24
2022-11-30查看详情 > -
Regulatory and procedural guideline: IRIS guide to registration and RPIs-2022/11/21
2022-11-30查看详情 > -
Regulatory and procedural guideline: List of centrally authorised products requiring a notification of a change for update of annexes-2022/11/18
2022-11-30查看详情 > -
Scientific guideline: Draft guideline on the development and data requirements of potency tests for cell-based therapy products and the relation to clinical efficacy-2022/11/18
2022-11-30查看详情 > -
Scientific guideline: Reflection paper on the criteria to be considered for the evaluation of new active substance (NAS) status of biological substances-2022/11/18
2022-11-30查看详情 > -
Regulatory and procedural guideline: CAT rules of procedure-2022/11/17
2022-11-30查看详情 > -
Regulatory and procedural guideline: Concept Paper on the revision of Annex 11 of the guidelines on Good Manufacturing Practice for medicinal products – Computerised Systems-2022/11/16
2022-11-30查看详情 >